Epithelioid sarcoma: An immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 30, Issue 2, 2003, Pages 114-117

  Lin, Lin ^a   Skacel, Marek ^a   Sigel, Jessica E ^a   Bergfeld, Wilma F ^a   Montgomery, Elizabeth ^b   Fisher, Cyril ^c   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 5; CYTOKERATIN 6; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIOID SARCOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR DIFFERENTIATION;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATINS; SARCOMA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037303029     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.00040.x     Document Type: Article

References (8)

1. Weiss SW, Goldblum JR. Epithelioid sarcoma. In: Soft tissue tumors, 4th edn. St Louis: Mosby, 2001; 1521.
2. Enzinger FM. Epithelioid sarcoma: a sarcoma simulating granuloma or a carcinoma. Cancer 1970; 26: 1029.
3. Chase DR, Enzinger FM. Epithelioid sarcoma, diagnosis, prognostic indicators and treatment. Am J Surg Pathol 1985; 9: 241.
4. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms. an immunohistochemical study of 509 cases. Mod Pathol 2002; 15: 6.
5. Ordoñez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998; 22: 1215.
6. van de Rijn M, Rouse RV. CD-34: a review. Appl Immunohistochem 1994; 2: 71.
7. Moll R, Dhouailly D, Sun TT. Expression of keratin 5 as a distinct feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14. Virchow Arch 1989; 58: 129.
8. Sigel JE, Skacel M, Bergfeld WF et al. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2001; 28: 520.